RxDoctor Payments Data

Nicole Victor

Nurse Practitioner · Oak Lawn, ILNPI 1740712090

Payments from drug & device makers

$6,796in general payments, 2019–2025

Across 67 payments — averaging $101.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Actelion Pharmaceuticals US, Inc.$5K
  • United Therapeutics Corporation$758
  • Bayer$416
  • Boehringer Ingelheim$184
  • Merck$167
  • Johnson & Johnson$36
  • plus $113 from 4 others

What the payments were for

  • Consulting fees$3,57853%
  • Travel & lodging$97214%
  • Food & beverage$2,14732%
  • Education$991%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,796 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$5,892
Medicare patients
48
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UptraviSelexipag87$2,099,429
Tyvaso DpiTreprostinil32$736,687
AdempasRiociguat44$616,282
OpsumitMacitentan11$137,764
Ambrisentan37$124,979
Tadalafil78$115,910
RemodulinTreprostinil Sodium13$37,589
JardianceEmpagliflozin23$25,059
FarxigaDapagliflozin Propanediol13$10,381
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$8,369
Sildenafil Citrate46$6,879
Torsemide102$2,350
Midodrine Hcl22$2,271
Potassium Chloride63$1,883
Klor-Con M20Potassium Chloride25$1,755

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Actelion Pharmaceuticals US, Inc.Uptravi, Opsumit$5,123$2,237,19398 claims
BayerAdempas$416$616,28244 claims
United Therapeutics CorporationRemodulin$758$37,58913 claims
Boehringer IngelheimJardiance$184$25,05923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Oak Lawn

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →